Neomorph, Inc., a biotechnology company advancing a new class of molecular glue degraders to target historically undruggable proteins, today announced the appointment of Bob Hugin, former Chairman and ...
Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced the appointment of Michael "Mike" W. Bonney ...
Five years ago, former Dodgers pitcher Ross Stripling co-founded a financial services company. Nearly two years into ...
Professional antigen-presenting cells—monocytes and macrophages—engulf these proteins, digest them into short peptide ...
Dupilumab significantly improved esophageal distensibility and diameter in eosinophilic esophagitis at 24 weeks, alongside ...
Biotech dealmaking is on pace for a bumper year in 2026, with large drugmakers on an acquisition spree to boost their pipelines ahead of upcoming patent losses.
TURKU, FI / ACCESS Newswire / May 5, 2026 / Faron Pharmaceuticals Ltd. ("Faron") (AIM:FARN)(First North:FARON), a clinical-stage biopharmaceutical company focused on creating innovative immunotherapie ...
Accumulating evidence of possible benefit warrants randomized trials, experts say ...
European Hematology Association (EHA) oral presentation to report 67% hematological improvement, durable transfusion independence, and no treatment-related serious adverse events in ESA-refractory low ...
Corporations offer liability protection, simplifying capital raises and management structuring. Corporate operations face double taxation and strict regulatory demands, increasing overhead. Different ...
It’s a governing body made up of 125 elected representatives that exercises the powers of a local authority Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a ...
Lauren (Hansen) Holznienkemper is a lead editor for the small business vertical at Forbes Advisor, specializing in HR, payroll and recruiting solutions for small businesses. Using research and writing ...